Navigation Links
New rust resistance genes added to common beans
Date:6/4/2010

New cultivars of common bean developed by Agricultural Research Service (ARS) and university scientists could shore up the legume crop's defenses against the fungal disease common bean rust.

According to Talo Pastor-Corrales, an ARS plant pathologist in Beltsville, Md., the new cultivars possess two or more genes for resistance to the rust fungi. Most of the cultivars also harbor Ur-11, which is considered the most effective rust-resistance gene in the world.

Pastor-Corrales and his colleagues at the University of Nebraska and Colorado State University resorted to this multi-gene strategy in response to the high diversity of strains of the bean rust pathogen. Lately, virulent new races of rust that have overcome the Ur-3 resistance gene appeared in Michigan and North Dakota.

Until recently, this gene had been very effective in controlling rust in the United States, epecially in North Dakota and Michigan, the country's largest bean-growing states. Now, Ur-3-protected varieties that once withstood the disease are succumbing to it, and there's concern the new races will spread to other Northern Plains states where common beans are grown, such as Colorado and Nebraska.

Pastor-Corrales' search for novel sources of rust resistance in dry-, snap- and other common beans has taken him to 21 countries in the Americas and 11 in Africa. The battle against rust is complicated by the fact that races present in crop fields can vary from one year to the next, adds Pastor-Corrales, who leads a bean breeding project at the ARS Soybean Genomics and Improvement Research Unit in Beltsville.


'/>"/>

Contact: Jan Suszkiw
Jan.Suszkiw@ars.usda.gov
301-504-1630
United States Department of Agriculture-Research, Education, and Economics
Source:Eurekalert

Page: 1

Related biology news :

1. Researchers discover new strategies for antibiotic resistance
2. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
3. Binghamton University researchers investigate evolving malaria resistance
4. Drug could improve pregnancy outcomes in wider range of women with insulin resistance
5. Feline virus, antiviral drug studied to understand drug resistance
6. Manure management reduces levels of antibiotics and antibiotic resistance genes
7. High degree of resistance to antibiotics in Arctic birds
8. Gene that controls ozone resistance of plants could lead to drought-resistant crops
9. BARACLUDE data show low resistance over 5 years in nucleoside-naive hepatitis B patients
10. Common aquatic animals show extreme resistance to radiation
11. Ibuprofen or acetaminophen in long-term resistance training increases muscle mass/strength
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... and GREENWICH, Conn. , Feb. ... firm focused on venture growth investments in biotechnology ... Josh Richardson , M.D. to Managing Director. ... biotechnology companies.  He is a board observer at ... in Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, ...
(Date:2/16/2017)... CALABASAS, Calif. , Feb. 16, 2017 /PRNewswire/ ... on developing groundbreaking therapies to treat severe neurological ... in children treated with AGT-181, the company,s investigational ... syndrome (also known as mucopolysaccharidosis type I, or ... Phase 2 proof-of-concept (POC) study, presented today at ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , February 16, 2017 ... infusion of innovative telemedicine application, new and leading ... are experiencing a boom worldwide. The healthcare sector ... of technologies, services and new therapies for companies ... (TSX-V: RHT), Cellectar Biosciences, Inc. (NASDAQ: ...
Breaking Biology Technology: